Santa Ana Bio

Alameda, CA · Founded 2020 · Privately Held (backing)

Operator of a biotechnology company intended to develop precision immunology for autoimmune diseases. Santa Ana Bio is based in Alameda, CA and was founded in 2020. Its last known valuation is $270 million. It has raised $203 million across 3 recorded rounds; the latest was a $20 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$270.0M
Total raised
$203.0M
Last round
Early Stage VC
May 2024

Who backs Santa Ana Bio?

6 investors
InvestorType
Andreessen HorowitzVenture capital
GVVenture capital
RTW InvestmentsHedge fund
Versant VenturesVenture capital
Access Biotechnology—
TPG—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Santa Ana Bio investors

6 investors are on record for Santa Ana Bio, including Andreessen Horowitz, GV, RTW Investments and Versant Ventures. The early-stage round in May 2024 drew 10 investors.

Free account
More of Santa Ana Bio with a free account
  • ·Watch Santa Ana Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Santa Ana Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View